Implementing COVID-19 Testing in Massachusetts Phased Reopening Plans

August 12, 2020 12:00 PM - 1:00 PM

Webinar, click "live-stream" button to view

Add to Calendar 8/12/2020 12:00:00 PM 8/12/2020 1:00:00 PM Implementing COVID-19 Testing in Massachusetts Phased Reopening Plans

COVID-19 testing is a significant part of the answer to reopen our economy and our lives – and will remain crucial even after vaccines or therapies eventually become available. Municipalities, companies, universities, hospitals, school systems, and families want to know how and when they could implement testing or be tested so our society can reopen more fully and more confidently. Ideally, we want a highly reliable, rapid test that provides results in minutes. We hear it is taking 7+ days to get a test back due to the current surges in our country and it seems like test companies are way over capacity. How does the MassBio community implement testing? Is it even realistic now? What kind of testing should be implemented? We’ll hear from those who were on the forefront of implementing testing as part of their reopening strategy and get a pulse on how it is going. We’ll also address the shortfalls of current testing and offer strategies to undertake testing as a key component of your reopening plans.

Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only. 

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

Webinar, click "live-stream" button to view
Managing Director, Healthcare & Life Sciences Strategy
Jessica is a Managing Director in KPMG’s Healthcare and Life Sciences Strategy practice. Jessica started her career conducting bench research in synthetic biology and tissue engineering at UC Berkeley and UC San Diego and in drug encapsulation at Amylin Pharmaceuticals. She then earned an MS in mechanical engineering (focused on biomechanics) and an MBA, both from MIT. Since then, she has focused on helping pharma, diagnostics, private equity, and other clients grow their life sciences businesses both organically and inorganically. Prior to the COVID-19 pandemic, much of Jessica’s work focused on diagnostics. During this pandemic, she has leveraged her diagnostics expertise to support reference labs as they setup and scale up COVID-19 testing to hundreds of thousands of tests per day. She is also advising employers, universities, sport teams, and health systems on COVID-19 testing strategy and implementation.